BreStem Therapeutics' Unattributed Round

BreStem Therapeutics raised a round of funding on November 29, 2017.

BreStem is working to fight pulmonary fibrosis through stem cell therapy for lung regeneration. The company's method generates therapeutically-relevant amounts of lung stem cells that outperforms curr…

Articles about BreStem Therapeutics' Unattributed Round: